Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group” or “the Company”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”), has announced that it is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. […]

Work supports rapid development of an innovative plasmid vaccine against COVID-19 Cytiva to provide instruments and consumables to support Takara Bio’s effort to support development of DNA vaccine with Osaka University and AnGes, Inc. group Cytiva (formerly part of GE Healthcare Life Sciences), a global provider of technologies and services that advance and accelerate the […]

Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market. San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that […]

HSINCHU, Taiwan — Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a patent infringement complaint in the Wuhan People’s Court in China against Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, its agents and certified service providers, infringe one or more […]

Leading PCR and qPCR technology now available for high-throughput applications: With the Biometra TRobot IIand qTOWER³ auto, Analytik Jena presents two new thermal cyclers for fully automated PCR and qPCR applications. Both systems follow a modular approach and are designed as open systems. Both devices are particularly robust and were developed for unattended continuous operation. Customers of […]

New solution accelerates research validation in cancer, immunology and drug discovery PLEASANTON, Calif. — Building on its earlier reveal at the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG) today launched its Targeted Gene Expression Solution for single cell and shortly following for spatial genomic research. Targeted Gene Expression […]

Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® […]

BEIJING–(BUSINESS WIRE)– Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI. The partnership will support DARUI at developing pathogenic microorganism detection products and applying for registration of reagent kits using the NGS sequencer GENETRON S5 (Registration Number 20193220820). Featuring diverse application […]

Lexogen and BlueBee have launched a new, web-based data analysis portal to provide a more user‑friendly experience for Lexogen kit users analyzing RNA sequencing data. With the Lexogen web solution configuration on the BlueBee Genomics Platform, data upload is easier than ever— files can be uploaded with a simple “drag and drop” function (Figure 1) […]